Tsumura & Co. (TYO:4540)

Market Cap	284.41B
Revenue (ttm)	180.50B
Net Income (ttm)	25.62B
Shares Out	74.71M
EPS (ttm)	338.33
PE Ratio	11.25
Forward PE	11.04
Dividend	136.00 (3.57%)
Ex-Dividend Date	Sep 29, 2025

Volume	341,300
Average Volume	397,975
Open	3,790.00
Previous Close	3,807.00
Day's Range	3,768.00 - 3,802.00
52-Week Range	3,306.00 - 5,138.00
Beta	-0.07
RSI	66.56
Earnings Date	Nov 10, 2025

About Tsumura & Co.

Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 4,272
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4540

Financial Performance

In 2024, Tsumura & Co.'s revenue was 181.09 billion, an increase of 20.05% compared to the previous year's 150.85 billion. Earnings were 32.43 billion, an increase of 94.10%.